Bussiness Ideas

NeuraXion Labs is an AI-first healthcare innovation company committed to transforming global healthcare through artificial intelligence and deep tech. Our mission is to democratize access to high-quality cancer diagnostics by addressing critical diagnostic bottlenecks and enabling equitable care worldwide. At the heart of our work is TumorXpert™, a patented neuro-symbolic AI platform that combines deep learning, symbolic reasoning, and explainable AI to deliver highly accurate, reliable, and transparent cancer detection across multiple tumor types. Designed as India’s first large foundation model for oncology diagnostics, TumorXpert™ empowers healthcare systems to improve patient outcomes, reduce costs, and scale advanced diagnostics to underserved regions, shaping the future of global health. Problem Current diagnostic depend heavily on radiologists’ manual MRI interpretation, process is slow, prone to human error, leading to delayed treatments, higher mortality, and rising healthcare costs. With the global cancer burden projected to rise by 47% by 2040 , and agencies projecting a substantial increase in new cancer cases especially in LMICs regions, leading to shortage of specialist radiology capacity. NeuraXion Labs can address this critical gap with TumorXpert™, a patented, India-born AI platform engineered specifically for high-stakes cancer and tumor diagnostics. Innovation at core through Breakthrough Architecture, Not a point solution, but a scalable Unified Foundation Model for Oncology, cancer diagnostics, adaptable for brain, lung, breast, skin, gastrointestinal, throat, and other cancers. Economic Value: By enabling early and accurate diagnosis, TumorXpert™ minimizes repeat scans, cuts misdiagnosis-related costs, and curbs late-stage treatment expenditures—creating substantial cost savings for healthcare providers and payers. Scalability & Accessibility Secured cloud-ready, hardware-light deployment ensures rapid adoption across government hospitals, rural health centers, and global facilities with minimal IT investment. This allows rapid deployment across healthcare facilities with minimal IT investment, including public hospitals and rural clinics. Technology and Scientific Moat 8 peer-reviewed publications and clinical accuracy stand at 99.9%, outperforming global AI solutions. It performs better than all and cited through multiple International Journals.

Startup Teams

• 1 Dr Ambuj Kathuria (Founder)
• 2 Chandra Gupt (Director)

Incubation Details

• Incubator Name
  G L Bajaj Center for Research and Incubation
• Incubator Host Institution
  GL Bajaj Institute of Technology and Management
• State
  Uttar Pradesh
• City
  Gautam Buddha Nagar